The trial will evaluate the efficacy of psilocybin in Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA). The data is expected in early 2022
This test can be run on commonly available qPCR cyclers, thereby, bypassing the need to perform expensive and time-consuming Next-Generation Sequencing
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
The focus is on wellness and personal care products
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
At present 18 per cent of the local pharmaceutical market is under government's price control
Key trends indicate that AI-based solutions, cloud-based healthcare solutions and digital transformations will be the key in the years to come.
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
Results reinforce the well-established safety profile of Dupixent - the first-ever biologic medicine for atopic dermatitis currently approved for patients as young 6 years old
This is Enzene Biosciences third biosimilar to be approved
Subscribe To Our Newsletter & Stay Updated
